Smartphone Tests Detect Frontotemporal Dementia
Cognitive tests administered through a smartphone mobile application (app) accurately and reliably detected frontotemporal lobar degeneration (FTLD), also known as frontotemporal dementia (FTD), an observational study showed. The smartphone tests had moderate to excellent internal consistency and test-retest reliability (intraclass correlation coefficient range of 0.77-0.95), according to Adam Staffaroni, PhD, of the University of California […]
No Survival Benefit to Higher Intranasal Naloxone Dose
There was no difference in survival between recipients of 4-mg or 8-mg intranasal naloxone (Narcan) administered by law enforcement, according to data from New York state. A review of 354 naloxone administration reports from New York State Police from March 2022 to August 2023 showed that 99% of people who received the 8-mg dose and […]
Artesunate: Malaria Treatment Uses, Warnings, Side Effects, Dosage
What is artesunate, and what is it used for? Artesunate is a medication administered intravenously to treat serious malaria, a disease with high fevers, shaking chills, and flu-like illness, in adults and children. Malaria is caused by microscopic unicellular parasites belonging to the Plasmodium species, and the disease caused by Plasmodium falciparum is the type […]
RSV Vaccine Holds Promise for Pregnant Women
A bivalent protein-based vaccine against respiratory syncytial virus (RSV) administered during pregnancy was safe and led to higher neutralizing antibody responses in mothers, as well as evidence of protection in their infants, an interim analysis of a phase IIb trial found. The geometric mean ratios of 50% neutralizing antibody titers against RSV A and B […]
Intranasal flu vaccine with nanoparticles offers robust protection
An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers in the Institute for Biomedical Sciences at Georgia State University. The intranasal vaccine contributed to multifaceted immune responses, leading to robust cross protection against influenza in mice. The vaccine […]
Will We Ever Reach Biden’s Moving Vax Target?
As of this writing, over 320 million COVID-19 vaccines have been administered in the U.S., with 56% of adults fully and 66% at least partially vaccinated. Based on these numbers, it’s unsurprising that the White House conceded it wouldn’t hit President Biden’s goal of vaccinating 70% of adults, at least partially, by July 4. The […]